Top

Published in:

01-08-2019 | Alzheimer's Disease | Original Article

Melatonin-pretreated adipose-derived mesenchymal stem cells efficeintly improved learning, memory, and cognition in an animal model of Alzheimer's disease

Authors: Ebrahim Nasiri, Akram Alizadeh, Amaneh Mohammadi Roushandeh, Rouhollah Gazor, Nasrin Hashemi-Firouzi, Zoleikha Golipoor

Published in: Metabolic Brain Disease | Issue 4/2019

Abstract

Currently, mesenchymal stem cells (MSCs) based therapy has extensive attraction for Alzheimer’s disease (AD). However, low survival rate of MSCs after transplantation is a huge challenging. The current study aimed to improve adipose-derived MSCs (AD-MSCs)-based therapy by their pre-treatment with melatonin (MT) ‘a well-known antioxidant’ in an animal model of AD. In this study, after isolating rat AD-MSCs from the epididymal white adipose tissues, the cells were pretreated with 5μM of MT for 24 hours. Forty male Wistar rats were randomly allocated to control, sham, amyloid-beta (Aβ) peptide, AD-MSCs and MT-pretreated ADMSCs groups. The novel object recognition, passive avoidance test, Morris water maze and open field test were performed two months following the cell transplantation. The rats were sacrificed 69 days following cell therapy. The brain tissues were removed for histopathological analysis and also immunohistochemistry was performed for two Aβ1-42 and Iba1 proteins. It has been revealed that both AD-MSCs and MT-AD-MSCs migrated to brain tissues after intravenous transplantation. However, MT-ADMSCs significantly improved learning, memory and cognition compared with AD-MSCs (P<0.05). Furthermore, clearance of Aβ deposition and reduction of microglial cells were significantly increased in the MT-ADMSCs compared with AD-MSCs. Although stem cell therapy has been introduced as a promising strategy in neurodegenerative diseases, however, its therapeutic properties are limited. It is suggested that pretreatment of MSCs with melatonin partly would increase the cells efficiency and consequently could decrease AD complication including memory and cognition.

Ager RR, Davis JL, Agazaryan A, Benavente F, Poon WW, LaFerla FM, Blurton-Jones M (2015) Human neural stem cells improve cognition and promote synaptic growth in two complementary transgenic models of Alzheimer's disease and neuronal loss. Hippocampus 25:813–826CrossRefPubMedPubMedCentral

Amstrup A, Sikjaer T, Mosekilde L, Rejnmark L (2013) Melatonin and the skeleton. Osteoporos Int 24:2919–2927CrossRefPubMed

Asadbegi M, Yaghmaei P, Salehi I, Komaki A, Ebrahim-Habibi A (2017) Investigation of thymol effect on learning and memory impairment induced by intrahippocampal injection of amyloid beta peptide in high fat diet-fed rats. Metab Brain Dis 32:827–839CrossRefPubMed

Bali P, Lahiri DK, Banik A, Nehru B, Anand A (2017) Potential for stem cells therapy in Alzheimer’s disease: do neurotrophic factors play critical role? Curr Alzheimer Res 14:208–220CrossRefPubMedPubMedCentral

Campos AC, Fogaca MV, Aguiar DC, Guimaraes FS (2013) Animal models of anxiety disorders and stress. Revista brasileira de psiquiatria (Sao Paulo, Brazil : 1999) 35(Suppl 2):S101–S111. https://doi.org/10.1590/1516-4446-2013-1139 CrossRef

Cardinali DP, Esquifino AI, Srinivasan V, Pandi-Perumal SR (2008) Melatonin and the immune system in aging. Neuroimmunomodulation 15:272–278CrossRefPubMed

Carpentieri A, Areco V, de Barboza GD, Rivoira MA, Guizzardi S, de Talamoni NT (2016) Melatonin: Basic and Clinical Aspects. In: Melatonin, Neuroprotective Agents and Antidepressant Therapy. Springer, pp 55–64

Cetin F, Yazihan N, Dincer S, Akbulut G (2013) The effect of intracerebroventricular injection of beta amyloid peptide (1-42) on caspase-3 activity, lipid peroxidation, nitric oxide and NOS expression in young adult and aged rat brain. Turk Neurosurg 23:144–150PubMed

Chen HH et al (2014a) Additional benefit of combined therapy with melatonin and apoptotic adipose-derived mesenchymal stem cell against sepsis-induced kidney injury. J Pineal Res 57:16–32CrossRefPubMed

Chen YT et al (2014b) Melatonin treatment further improves adipose-derived mesenchymal stem cell therapy for acute interstitial cystitis in rat. J Pineal Res 57:248–261CrossRefPubMed

Choi SS, Lee S-R, Kim SU, Lee HJ (2014) Alzheimer's disease and stem cell therapy. Exp Neurobiol 23:45–52CrossRefPubMedPubMedCentral

Eftekharzadeh M et al (2015) The effect of intrathecal delivery of bone marrow stromal cells on hippocampal neurons in rat model of Alzheimer’s disease Iranian journal of basic medical sciences, vol 18, p 520

Espino J, Pariente JA, Rodríguez AB (2012) Oxidative stress and immunosenescence: therapeutic effects of melatonin Oxidative medicine and cellular longevity 2012

Esteban-Zubero E et al (2016) Potential benefits of melatonin in organ transplantation: a review. J Endocrinol 229:R129–R146CrossRefPubMed

Etaee F, Asadbegi M, Taslimi Z, Shahidi S, Sarihi A, Asl SS, Komaki A (2017) The effects of methamphetamine and buprenorphine, and their interaction on anxiety-like behavior and locomotion in male rats. Neurosci Lett 655:172–178CrossRefPubMed

Gholami M, Saki G, Hemadi M, Khodadadi A, Mohammadi-asl J (2014) Melatonin improves spermatogonial stem cells transplantation efficiency in azoospermic mice. Iran J Basic Med Sci 17(93)

Haider KH, Ashraf M (2012) Preconditioning approach in stem cell therapy for the treatment of infarcted heart. In: Prog Mol Biol Transl Sci, vol 111. Elsevier, pp 323-356

Hasanein P, Shahidi S (2011) Effects of Hypericum perforatum extract on diabetes-induced learning and memory impairment in rats. Phytother Res 25:544–549CrossRefPubMed

Jahnke G, Marr M, Myers C, Wilson R, Travlos G, Price C (1999) Maternal and developmental toxicity evaluation of melatonin administered orally to pregnant Sprague-Dawley rats. Toxicological Sciences: an Official Journal of the Society of Toxicology 50:271–279CrossRef

Kan I, Barhum Y, Melamed E, Offen D (2011) Mesenchymal stem cells stimulate endogenous neurogenesis in the subventricular zone of adult mice. Stem Cell Rev Rep 7:404–412CrossRefPubMed

Khatibi S, Taban ZF, Halabian R, Roushandeh AM (2017) Combined preconditioning with hypoxia and Hydrogen Peroxide Improved efficiency of Mesenchymal Stem Cell in cell culture. Entomol Appl Sci Lett 3:89–96

Kim S, Chang K-A, Park H-G, Ra JC, Kim H-S, Suh Y-H (2012) The preventive and therapeutic effects of intravenous human adipose-derived stem cells in Alzheimer’s disease mice. PLoS One 7:e45757CrossRefPubMedPubMedCentral

Kim JA et al (2015) Neural stem cell transplantation at critical period improves learning and memory through restoring synaptic impairment in Alzheimer's disease mouse model. Cell Death Dis 6:e1789. https://doi.org/10.1038/cddis.2015.138 CrossRefPubMedPubMedCentral

Komaki A, Khalili A, Salehi I, Shahidi S, Sarihi A (2014) Effects of exposure to an extremely low frequency electromagnetic field on hippocampal long-term potentiation in rat. Brain Res 1564:1–8CrossRefPubMed

Kommaddi RP et al (2018) Abeta mediates F-actin disassembly in dendritic spines leading to cognitive deficits in Alzheimer's disease. J Neurosci 38:1085–1099. https://doi.org/10.1523/jneurosci.2127-17.2017 CrossRefPubMedPubMedCentral

Koyama H, Nakade O, Takada Y, Kaku T, Lau KHW (2002) Melatonin at pharmacologic doses increases bone mass by suppressing resorption through down-regulation of the RANKL-mediated osteoclast formation and activation. J Bone Miner Res 17:1219–1229CrossRefPubMed

Lee JK, Jin HK, Endo S, Schuchman EH, Carter JE, Js B (2010) Intracerebral transplantation of bone marrow-derived mesenchymal stem cells reduces amyloid-beta deposition and rescues memory deficits in Alzheimer's disease mice by modulation of immune responses. Stem Cells 28:329–343PubMed

Lee SJ, Jung YH, Oh SY, Yun SP, Han HJ (2014) Melatonin enhances the human mesenchymal stem cells motility via melatonin receptor 2 coupling with Gαq in skin wound healing. J Pineal Res 57:393–407CrossRefPubMed

Lemmens MA, Sierksma AS, Rutten BP, Dennissen F, Steinbusch HW, Lucassen PJ, Schmitz C (2011) Age-related changes of neuron numbers in the frontal cortex of a transgenic mouse model of Alzheimer’s disease. Brain Struct Funct 216:227CrossRefPubMedPubMedCentral

Lister RG (1987) The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 92:180–185PubMed

Liu XB, Wang JA, Ogle ME, Wei L (2009) Prolyl hydroxylase inhibitor dimethyloxalylglycine enhances mesenchymal stem cell survival. J Cell Biochem 106:903–911CrossRefPubMed

Liu J, Clough SJ, Hutchinson AJ, Adamah-Biassi EB, Popovska-Gorevski M, Dubocovich ML (2016) MT1 and MT2 melatonin receptors: a therapeutic perspective. Annu Rev Pharmacol Toxicol 56:361–383CrossRefPubMed

Luchetti F et al (2010) Melatonin signaling and cell protection function. FASEB J 24:3603–3624CrossRefPubMed

Malin DH et al (2001) Hippocampal injections of amyloid beta-peptide 1-40 impair subsequent one-trial/day reward learning. Neurobiol Learn Mem 76:125–137. https://doi.org/10.1006/nlme.2000.3991 CrossRefPubMed

Mandrekar-Colucci S, Landreth GE (2010) Microglia and inflammation in Alzheimer's disease. CNS Neurol Disord Drug Targets 9:156–167CrossRefPubMed

Mortezaee K et al (2016) Melatonin pretreatment enhances the homing of bone marrow-derived mesenchymal stem cells following transplantation in a rat model of liver fibrosis. Iran Biomed J 20:207PubMedPubMedCentral

Munoz JR, Stoutenger BR, Robinson AP, Spees JL, Prockop DJ (2005) Human stem/progenitor cells from bone marrow promote neurogenesis of endogenous neural stem cells in the hippocampus of mice. Proc Natl Acad Sci 102:18171–18176CrossRefPubMed

Ohsawa K, Imai Y, Sasaki Y, Kohsaka S (2004) Microglia/macrophage-specific protein Iba1 binds to fimbrin and enhances its actin-bundling activity. J Neurochem 88:844–856CrossRefPubMed

Paul CA, Beltz B, Berger-Sweeney J (2007) Testing spatial and nonspatial learning using a morris water maze. CSH protocols 2007:pdb.prot4801. https://doi.org/10.1101/pdb.prot4801 CrossRefPubMed

Rafat A, Roushandeh AM, Alizadeh A, Hashemi-Firouzi N, Golipoor Z (2018) Comparison of the melatonin preconditioning efficacy between bone marrow and adipose-derived mesenchymal stem cells. Cell Journal (Yakhteh) 20:450

Rockenstein E et al (2015) Neuro-peptide treatment with Cerebrolysin improves the survival of neural stem cell grafts in an APP transgenic model of Alzheimer disease. Stem Cell Res 15:54–67CrossRefPubMed

Roushandeh AM, Bahadori M, Roudkenar MH (2017) Mesenchymal stem cell-based therapy as a new horizon for kidney injuries. Arch Med Res 48:133–146CrossRefPubMed

Ruzicka J, Kulijewicz-Nawrot M, Rodrigez-Arellano JJ, Jendelova P, Sykova E (2016) Mesenchymal stem cells preserve working memory in the 3xTg-AD mouse model of Alzheimer’s disease. Int J Mol Sci 17:152CrossRefPubMedCentral

Sánchez-Barceló E, Mediavilla M, Tan D, Reiter R (2010) Clinical uses of melatonin: evaluation of human trials. Curr Med Chem 17:2070–2095CrossRefPubMed

Sarlus H, Heneka MT (2017) Microglia in Alzheimer’s disease. J Clin Invest 127:3240–3249CrossRefPubMedPubMedCentral

Shi Z et al (2012) Evaluation of an Abeta(1-40)-induced cognitive deficit in rat using a reward-directed instrumental learning task. Behav Brain Res 234:323–333. https://doi.org/10.1016/j.bbr.2012.07.006 CrossRefPubMed

Shi Z et al (2015) Tong Luo Jiu Nao ameliorates Abeta1-40-induced cognitive impairment on adaptive behavior learning by modulating ERK/CaMKII/CREB signaling in the hippocampus. BMC Complement Altern Med 15:55. https://doi.org/10.1186/s12906-015-0584-9 CrossRefPubMedPubMedCentral

Son JH, Cho YC, Sung IY, Kim IR, Park BS, Kim YD (2014) Melatonin promotes osteoblast differentiation and mineralization of MC3T3-E1 cells under hypoxic conditions through activation of PKD/p38 pathways. J Pineal Res 57:385–392CrossRefPubMed

Tan SS, Han X, Sivakumaran P, Lim SY, Morrison WA (2016) Melatonin Protects Human Adipose-Derived Stem Cells from Oxidative Stress and Cell Death. Arch Plast Surg 43:237–241. https://doi.org/10.5999/aps.2016.43.3.237 CrossRefPubMedPubMedCentral

Tang YL, Tang Y, Zhang YC, Qian K, Shen L, Phillips MI (2005) Improved graft mesenchymal stem cell survival in ischemic heart with a hypoxia-regulated heme oxygenase-1 vector. J Am Coll Cardiol 46:1339–1350CrossRefPubMed

Tang Y et al (2014) Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell Transplant 23:1279–1291CrossRefPubMed

Tong LM, Fong H, Huang Y (2015) Stem cell therapy for Alzheimer’s disease and related disorders: current status and future perspectives. Exp Mol Med 47:e151CrossRefPubMedPubMedCentral

Van LP (1977) Ketamine and xylazine for surgical anesthesia in rats. J Am Vet Med Assoc 171:842–844

Yan K et al (2013) Bone marrow-derived mesenchymal stem cells maintain the resting phenotype of microglia and inhibit microglial activation. PLoS One 8:e84116CrossRefPubMedPubMedCentral

Yan Y, Ma T, Gong K, Ao Q, Zhang X, Gong Y (2014) Adipose-derived mesenchymal stem cell transplantation promotes adult neurogenesis in the brains of Alzheimer's disease mice. Neural Regen Res 9:798CrossRefPubMedPubMedCentral

Yip HK et al (2013) Melatonin treatment improves adipose-derived mesenchymal stem cell therapy for acute lung ischemia–reperfusion injury. J Pineal Res 54:207–221CrossRefPubMed

Yu SP, Wei Z, Wei L (2013) Preconditioning strategy in stem cell transplantation therapy. Transl Stroke Res 4:76–88CrossRefPubMedPubMedCentral

Zhang HM, Zhang Y (2014) Melatonin: a well-documented antioxidant with conditional pro-oxidant actions. J Pineal Res 57:131–146CrossRefPubMed

Zhang L et al (2010) Melatonin inhibits adipogenesis and enhances osteogenesis of human mesenchymal stem cells by suppressing PPARγ expression and enhancing Runx2 expression. J Pineal Res 49:364–372CrossRefPubMed

Zhao L et al (2017) Acupuncture improves cerebral microenvironment in mice with Alzheimer’s disease treated with hippocampal neural stem cells. Mol Neurobiol 54:5120–5130CrossRefPubMed

Title: Melatonin-pretreated adipose-derived mesenchymal stem cells efficeintly improved learning, memory, and cognition in an animal model of Alzheimer's disease
Authors: Ebrahim Nasiri
Akram Alizadeh
Amaneh Mohammadi Roushandeh
Rouhollah Gazor
Nasrin Hashemi-Firouzi
Zoleikha Golipoor
Publication date: 01-08-2019
Publisher: Springer US
Keywords: Alzheimer's Disease
Alzheimer's Disease
Published in: Metabolic Brain Disease / Issue 4/2019
Print ISSN: 0885-7490
Electronic ISSN: 1573-7365
DOI: https://doi.org/10.1007/s11011-019-00421-4

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Melatonin-pretreated adipose-derived mesenchymal stem cells efficeintly improved learning, memory, and cognition in an animal model of Alzheimer's disease

Abstract

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 4/2019

Exploring the multifaceted neuroprotective actions of Emblica officinalis (Amla): a review

Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations

Neuroprotective effects of lovastatin in the pilocarpine rat model of epilepsy according to the expression of neurotrophic factors

Cortico-hippocampal memory enhancing activity of hesperetin on scopolamine-induced amnesia in mice: role of antioxidant defense system, cholinergic neurotransmission and expression of BDNF

Hepatocellular carcinoma up-regulated long non-coding RNA: a putative marker in multiple sclerosis

Association of long noncoding RNA H19 polymorphisms with the susceptibility and clinical features of ischemic stroke in southern Chinese Han population